The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b study of panobinostat in combination with lenalidomide, bortezomib, and dexamethasone in relapsed refractory multiple myeloma.
 
Jacob Laubach
Research Funding - Celgene; Millennium; Novartis; Onyx
 
Sascha Alexander Tuchman
No Relationships to Disclose
 
Jacalyn Rosenblatt
No Relationships to Disclose
 
Robert Redd
No Relationships to Disclose
 
Kathleen Colson
No Relationships to Disclose
 
Ashley Motta
No Relationships to Disclose
 
Kathleen Fitzpatrick
No Relationships to Disclose
 
Edie Weller
No Relationships to Disclose
 
Paul G. Richardson
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genmab; Johnson & Johnson; Millennium; Novartis; Oncopeptides
Research Funding - Celgene; Millennium